A company dedicated to facilitating the due dilligence for pharmaceutical partnerships has a newly-testimonial from none other than... Mark Varney:
"ShareVault's focus on speed helps us accelerate the due diligence process. Some of our clinical trial results documents contain thousands of pages, yet our users can open them instantly from ShareVault.". – Mark Varney CEO Cortex Pharmaceuticals
In my morbid obsession with this misbegotten company, I often do searches for anything on the net pertaining to cortex pharmaceuticals that has appeared in the last 24 hours, so I know this is new.
The fact that ShareVault is posting his testimonial means that corx is using the service, and strongly suggests that a splashy deal is imminent. Otherwise, it doesn't make much sense for ShareVault to be trumpeting a penny stock.